Factors Associated With Discussing High Blood Pressure Readings in Clinical Notes
American Journal of Hypertension · 2025
DOI: 10.1093/ajh/hpae153 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hypertension, 2025. Verfasst von Cole G Chapman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice and Science, University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Hypertension, Blood Pressure Determination, Blood Pressure, Electronic Health Records. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, National Center for Advancing Translational Science, NCATS NIH HHS.
Abstract (Originalsprache)
BACKGROUND Blood pressure (BP) is routinely measured and recorded at healthcare visits, but high BP (HBP) measurements are not always discussed in clinical notes. Our objective was to identify patient- and visit-level factors associated with discussion of HBP measurements in clinical notes, among patients without prior diagnosis of hypertension. METHODS Data from 2016 to 2022 for all patients with any BP record of 140/90 mmHg or greater were obtained from University of Iowa Hospitals and Clinics electronic medical records. Patients with any prior hypertension diagnosis were excluded. We used a multi-level regression model to evaluate differences in the rates of discussing HBP. The model included varying intercepts for visit specialty and non-varying slopes and intercepts for patient- and visit-level features. RESULTS The final sample included 278,766 outpatient visits for 27,423 patients, of which 61,739 visits had HBP. Only 31% of visits with HBP had associated clinical notes with a discussion of HBP. Even in primary-care-related clinics, HBP measurements were discussed in only 70% of visits. Factors associated with decreased odds of HBP being discussed in clinical notes included fever (OR: 0.46; 95%CI: 0.24–0.86) or external injury or pain (0.84; 0.79–0.90), and a larger number of comorbidities (6+: 0.27; 0.22–0.32). Discussion of HBP in clinical notes was more likely among visits of patients with prior visits where HBP was discussed in clinical notes (12.36; 11.75–13.01). CONCLUSIONS We found that discussion of HBP is relatively uncommon. Increasing discussion of hypertension in clinical notes could decrease hypertension-related diagnostic inertia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy Practice and Science, University of Iowa, Iowa City, Iowa, USA.
- Department of Internal Medicine, University of Iowa, Iowa City, Iowa, USA.
ORCID-Profile: Linnea A Polgreen
Förderung
- NHLBI NIH HHS
- National Center for Advancing Translational Science
- NCATS NIH HHS
- National Heart, Lung, and Blood Institute
Zitieren
APA
Chapman, C. G., Polgreen, P. M., Suneja, M., Carter, B. L., & Polgreen, L. A. (2025). Factors Associated With Discussing High Blood Pressure Readings in Clinical Notes. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpae153
Vancouver
Chapman CG, Polgreen PM, Suneja M, Carter BL, Polgreen LA. Factors Associated With Discussing High Blood Pressure Readings in Clinical Notes. American Journal of Hypertension. 2025. doi:10.1093/ajh/hpae153
BibTeX
@article{Chapman2025,
author = {Chapman, Cole G and Polgreen, Philip M and Suneja, Manish and Carter, Barry L and Polgreen, Linnea A},
title = {Factors Associated With Discussing High Blood Pressure Readings in Clinical Notes},
journal = {American Journal of Hypertension},
year = {2025},
doi = {10.1093/ajh/hpae153}
}
EUVIMED